IP Library › Granted Patent US 11,007,172
Granted Patent B2
US 11,007,172 · App. 16/329,154 · Granted May 18, 2021

Agent for eliminating senescent cells

Inventor: Tohru Minamino (Niigata, JP)
Assignees: NIIGATA UNIVERSITY; MITSUBISHI TANABE PHARMA CORPORATION
A61K31/381A61K45/00A61P7/02A61P43/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,007,172
App. No.
16/329,154
Granted
May 18, 2021
Kind
B2
Abstract

The present invention provides an agent or pharmaceutical composition for eliminating senescent cells, comprising an SGLT2 inhibitor.

Claims (1)

1. A method for reducing or eliminating senescent cells in a subject in need thereof, the method comprising administrating an effective amount of an SGLT2 inhibitor to the subject in need thereof to reduce or eliminate senescent cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2019
From: MINAMINO, TOHRU
To: NIIGATA UNIVERSITY; MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 049021/0490 →
Priority Claims (1)
JP JP2016-167679 · Aug 30, 2016 · national
Continuity (1)
Related Publication 20190192482A1 · Jun 27, 2019
Cited By (1)
US 12,746,198